免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

AmCAD-UT Detection 2.2

K号: K180006 · 2018-08-31

决定日期2018-08-31
产品代码LLZ
咨询委员会RA
决定实质等同

器械摘要

AmCAD-UT Detection 2.2 is the device name listed in this FDA 510(k) record. The listed applicant is Amcad Biomed Corporation. It received FDA 510(k) clearance on 2018-08-31 under 510(k) number K180006. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the AmCAD-UT Detection 2.2?

AmCAD-UT Detection 2.2 is a medical device that received FDA 510(k) clearance on 2018-08-31. The listed applicant is Amcad Biomed Corporation. The 510(k) number is K180006.

When did AmCAD-UT Detection 2.2 receive FDA 510(k) clearance?

AmCAD-UT Detection 2.2 received FDA 510(k) clearance on 2018-08-31, under 510(k) number K180006.

Who is the listed applicant for AmCAD-UT Detection 2.2?

The FDA 510(k) record lists Amcad Biomed Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AmCAD-UT Detection 2.2?

The FDA product code for AmCAD-UT Detection 2.2 is LLZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Amcad Biomed Corporation为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:LLZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑